Johnson Investment Counsel Inc Regeneron Pharmaceuticals, Inc. Transaction History

Johnson Investment Counsel Inc

  • $10.1 Billion
  • Q3 2024

A detailed history of Johnson Investment Counsel Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 280 shares of REGN stock, worth $195,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares
280
Previous 225 24.44%
Holding current value
$195,126
Previous $236,000 24.58%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$1024.09 - $1201.76 $56,324 - $66,096
55 Added 24.44%
280 $294,000
Q1 2024

May 09, 2024
BUY
$902.69 - $993.35 $203,105 - $223,503
225 New
225 $216,000
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $512,413 - $624,833
-740 Reduced 68.52%
340 $279,000
Q2 2023

Aug 10, 2023
SELL
$700.03 - $830.35 $7,000 - $8,303
-10 Reduced 0.92%
1,080 $776,000
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $10,207 - $12,404
15 Added 1.4%
1,090 $895,000
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $67,765 - $73,573
-96 Reduced 8.2%
1,075 $775,000
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $13,775 - $17,383
24 Added 2.09%
1,171 $807,000
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $43,319 - $58,368
79 Added 7.4%
1,147 $678,000
Q1 2022

May 11, 2022
BUY
$595.12 - $698.43 $27,970 - $32,826
47 Added 4.6%
1,068 $746,000
Q4 2021

Feb 15, 2022
SELL
$543.48 - $670.97 $2,717 - $3,354
-5 Reduced 0.49%
1,021 $645,000
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $10,906 - $12,938
19 Added 1.89%
1,026 $621,000
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $1,891 - $2,234
4 Added 0.4%
1,007 $562,000
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $13,401 - $16,446
30 Added 3.08%
1,003 $475,000
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $1,434 - $1,823
3 Added 0.31%
973 $470,000
Q2 2020

Aug 13, 2020
SELL
$493.32 - $643.92 $123,330 - $160,980
-250 Reduced 20.49%
970 $605,000
Q1 2020

May 20, 2020
SELL
$336.18 - $494.43 $8,068 - $11,866
-24 Reduced 1.93%
1,220 $596,000
Q4 2019

Feb 13, 2020
SELL
$274.13 - $376.51 $21,382 - $29,367
-78 Reduced 5.9%
1,244 $467,000
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $16,407 - $19,103
-60 Reduced 4.34%
1,322 $367,000
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $163,881 - $226,906
547 Added 65.51%
1,382 $432,000
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $310,686 - $367,040
835 New
835 $342,000

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
82.7M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email